OAKLAND, Calif., Aug. 8, 2019 /PRNewswire-PRWeb/ -- Promaxo, the pioneer in the development of in-office MRI, announced today that it has closed $8M round of financing from a group of super angels and strategic investors.
Promaxo will use the funding to accelerate the clinical launch of its award-winning MRI platform in urology practices. The financing proceeds will fuel the development of Company's robotic-guidance system for live MRI interventions in a physician's office. Combined, these products will provide enhanced quality of care and superior patient experience.
"Promaxo's MRI platform is consistently being recognized as a breakthrough technology by healthcare and industry professionals," commented Amit Vohra, Promaxo's President and CEO. "The funding will help propel our in-office MRI to market and advance our product pipeline."
For more information, career opportunities or to discuss strategic partnerships, contact Promaxo at https://promaxo.com/contact-us/ or email us at [email protected].
About Promaxo
Promaxo is a medical technology company developing and commercializing customer-centric MRI systems and MRI based technologies that enhance patients' lives and redefine the standard of care. Using our proprietary technologies, we are bringing the first MRI and robotic-guidance system, for in-office use, to market.
SOURCE Promaxo
Share this article